{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:03:45Z","timestamp":1787238225356,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05397-0","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T14:03:50Z","timestamp":1690466630000},"page":"2807-2815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sj\u00f6gren\u2019s syndrome: a systematic review of individual patient data"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1594-7873","authenticated-orcid":false,"given":"Chandra Bhushan","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-1361","authenticated-orcid":false,"given":"Chirag Rajkumar","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9727-044X","authenticated-orcid":false,"given":"GSRSNK","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2472-3409","authenticated-orcid":false,"given":"Vishal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-7396","authenticated-orcid":false,"given":"Durga Prasanna","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-1243","authenticated-orcid":false,"given":"Aman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"issue":"2","key":"5397_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5114\/reum.2018.75521","volume":"56","author":"J Perzy\u0144ska-Mazan","year":"2018","unstructured":"Perzy\u0144ska-Mazan J, Ma\u015bli\u0144ska M, Gasik R (2018) Neurological manifestations of primary Sj\u00f6gren\u2019s syndrome. Reumatologia 56(2):99\u2013105","journal-title":"Reumatologia"},{"issue":"5","key":"5397_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/WCO.0b013e32833de6ab","volume":"23","author":"J Chai","year":"2010","unstructured":"Chai J, Logigian EL (2010) Neurological manifestations of primary Sjogren\u2019s syndrome. Curr Opin Neurol 23(5):509\u2013513","journal-title":"Curr Opin Neurol"},{"key":"5397_CR3","doi-asserted-by":"publisher","first-page":"1128315","DOI":"10.3389\/fneur.2023.1128315","volume":"14","author":"AM Afzali","year":"2023","unstructured":"Afzali AM, Moog P, Kalluri SR, Hofauer B, Knopf A, Kirschke JS, Hemmer B, Berthele A (2023) CNS demyelinating events in primary Sj\u00f6gren\u2019s syndrome: a single-center case series on the clinical phenotype. Front Neurol 14:1128315","journal-title":"Front Neurol"},{"issue":"6","key":"5397_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1177\/1352458508088941","volume":"14","author":"A Javed","year":"2008","unstructured":"Javed A, Balabanov R, Arnason BG, Kelly TJ, Sweiss NJ, Pytel P, Walsh R, Blair EA, Stemer A, Lazzaro M, Reder AT (2008) Minor salivary gland inflammation in Devic\u2019s disease and longitudinally extensive myelitis. Mult Scler (Houndmills, Basingstoke, England) 14(6):809\u2013814","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"2","key":"5397_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG, International Panel for NMO Diagnosis (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189","journal-title":"Neurology"},{"issue":"7","key":"5397_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMra1904655","volume":"387","author":"DM Wingerchuk","year":"2022","unstructured":"Wingerchuk DM, Lucchinetti CF (2022) Neuromyelitis optica spectrum disorder. N Engl J Med 387(7):631\u2013639","journal-title":"N Engl J Med"},{"issue":"6","key":"5397_CR7","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/bpa.12085","volume":"23","author":"AS Verkman","year":"2013","unstructured":"Verkman AS, Phuan PW, Asavapanumas N, Tradtrantip L (2013) Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO. Brain Pathol (Zurich, Switzerland) 23(6):684\u2013695","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"issue":"8","key":"5397_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1590\/0004-282X20140097","volume":"72","author":"DC Carvalho","year":"2014","unstructured":"Carvalho DC, Tironi TS, Freitas DS, Kleinpaul R, Talim NC, Lana-Peixoto MA (2014) Sj\u00f6gren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu. Arq Neuropsiquiatr 72(8):619\u2013624","journal-title":"Arq Neuropsiquiatr"},{"issue":"4","key":"5397_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrd4226","volume":"13","author":"AS Verkman","year":"2014","unstructured":"Verkman AS, Anderson MO, Papadopoulos MC (2014) Aquaporins: important but elusive drug targets. Nat Rev Drug Discov 13(4):259\u2013277","journal-title":"Nat Rev Drug Discov"},{"issue":"9257","key":"5397_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0140-6736(00)04140-4","volume":"357","author":"K Tsubota","year":"2001","unstructured":"Tsubota K, Hirai S, King LS, Agre P, Ishida N (2001) Defective cellular trafficking of lacrimal gland aquaporin-5 in Sj\u00f6gren\u2019s syndrome. Lancet (London, England) 357(9257):688\u2013689","journal-title":"Lancet (London, England)"},{"issue":"22","key":"5397_CR11","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1212\/WNL.0b013e3181a82621","volume":"72","author":"S Nishiyama","year":"2009","unstructured":"Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, Jin K, Aoki M, Fujihara K, Itoyama Y (2009) A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 72(22):1960\u20131961","journal-title":"Neurology"},{"issue":"1","key":"5397_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1352458511431077","volume":"18","author":"DM Wingerchuk","year":"2012","unstructured":"Wingerchuk DM, Weinshenker BG (2012) The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler (Houndmills, Basingstoke, England) 18(1):5\u201310","journal-title":"Mult Scler (Houndmills, Basingstoke, England)"},{"issue":"5","key":"5397_CR13","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1212\/01.WNL.0000049912.02954.2C","volume":"60","author":"DM Wingerchuk","year":"2003","unstructured":"Wingerchuk DM, Weinshenker BG (2003) Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 60(5):848\u2013853","journal-title":"Neurology"},{"key":"5397_CR14","first-page":"n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res Ed) 372:n71","journal-title":"BMJ (Clin Res Ed)"},{"key":"5397_CR15","volume-title":"JBI manual for evidence synthesis","author":"S Moola","year":"2020","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Lisy K, Qureshi R, Mattis P, Mu P (2020) Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z (eds) JBI manual for evidence synthesis. JBI, Adelaide"},{"issue":"1","key":"5397_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/archneurol.2007.17","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Z\u00e9phir H, Moder K, Weinshenker BG (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65(1):78\u201383","journal-title":"Arch Neurol"},{"key":"5397_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fneur.2020.00501","volume":"11","author":"JY Hor","year":"2020","unstructured":"Hor JY, Asgari N, Nakashima I, Broadley SA, Leite MI, Kissani N, Jacob A, Marignier R, Weinshenker BG, Paul F, Pittock SJ, Palace J, Wingerchuk DM, Behne JM, Yeaman MR, Fujihara K (2020) Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide. Front Neurol 11:501","journal-title":"Front Neurol"},{"issue":"28","key":"5397_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001145","volume":"94","author":"L Qiao","year":"2015","unstructured":"Qiao L, Wang Q, Fei Y, Zhang W, Xu Y, Zhang Y, Zhao Y, Zeng X, Zhang F (2015) The clinical characteristics of primary Sjogren\u2019s syndrome with neuromyelitis optica spectrum disorder in China: a STROBE\u2014compliant article. Medicine 94(28):e1145","journal-title":"Medicine"},{"issue":"2","key":"5397_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","volume":"75","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Kostov B, Solans R, Fraile G, Su\u00e1rez-Cuervo C, Casanovas A, Rasc\u00f3n FJ, Qanneta R, P\u00e9rez-Alvarez R, Ripoll M, Akasbi M, Pinilla B, Bosch JA, Nava-Mateos J, D\u00edaz-L\u00f3pez B, Morera-Morales ML, Gheitasi H, Retamozo S, Ramos-Casals M, SS Study Group, Autoimmune Diseases Study Group (GEAS), Spanish Society of Internal Medicine (SEMI) (2016) Systemic activity and mortality in primary Sj\u00f6gren syndrome: predicting survival using the EULAR-SS disease activity index (ESSDAI) in 1045 patients. Ann Rheum Dis 75(2):348\u2013355","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5397_CR20","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/acr.21610","volume":"64","author":"AS Malladi","year":"2012","unstructured":"Malladi AS, Sack KE, Shiboski SC, Shiboski CH, Baer AN, Banushree R, Dong Y, Helin P, Kirkham BW, Li M, Sugai S, Umehara H, Vivino FB, Vollenweider CF, Zhang W, Zhao Y, Greenspan JS, Daniels TE, Criswell LA (2012) Primary Sj\u00f6gren\u2019s syndrome as a systemic disease: a study of participants enrolled in an international Sj\u00f6gren\u2019s syndrome registry. Arthritis Care Res 64(6):911\u2013918","journal-title":"Arthritis Care Res"},{"issue":"8","key":"5397_CR21","first-page":"1067","volume":"30","author":"IA Alhomoud","year":"2009","unstructured":"Alhomoud IA, Bohlega SA, Alkawi MZ, Alsemari AM, Omer SM, Alsenani FM (2009) Primary Sjogren\u2019s syndrome with central nervous system involvement. Saudi Med J 30(8):1067\u20131072","journal-title":"Saudi Med J"},{"issue":"2","key":"5397_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2165\/00003495-200464020-00001","volume":"64","author":"SJ Rogers","year":"2004","unstructured":"Rogers SJ, Williams CS, Rom\u00e1n GC (2004) Myelopathy in Sj\u00f6gren\u2019s syndrome: role of nonsteroidal immunosuppressants. Drugs 64(2):123\u2013132","journal-title":"Drugs"},{"issue":"11","key":"5397_CR23","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","volume":"84","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, Klawiter EC, Sato DK, de Seze J, Wuerfel J, Banwell BL, Villoslada P, Saiz A, Fujihara K, Kim SH, Guthy-Jackson Charitable Foundation NMO International Clinical Consortium, Biorepository (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84(11):1165\u20131173","journal-title":"Neurology"},{"issue":"4","key":"5397_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neurad.2008.12.008","volume":"36","author":"C Cassinotto","year":"2009","unstructured":"Cassinotto C, Deramond H, Olindo S, Aveillan M, Smadja D, Cabre P (2009) MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis. J Neuroradiol Journal de neuroradiologie 36(4):199\u2013205","journal-title":"J Neuroradiol Journal de neuroradiologie"},{"issue":"4","key":"5397_CR25","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3174\/ajnr.A5551","volume":"39","author":"CG Chee","year":"2018","unstructured":"Chee CG, Park KS, Lee JW, Ahn HW, Lee E, Kang Y, Kang HS (2018) MRI features of aquaporin-4 antibody-positive longitudinally extensive transverse myelitis: insights into the diagnosis of neuromyelitis optica spectrum disorders. AJNR Am J Neuroradiol 39(4):782\u2013787","journal-title":"AJNR Am J Neuroradiol"},{"issue":"22","key":"5397_CR26","first-page":"3252","volume":"123","author":"DF Lin","year":"2010","unstructured":"Lin DF, Yan SM, Zhao Y, Zhang W, Li MT, Zeng XF, Zhang FC, Dong Y (2010) Clinical and prognostic characteristics of 573 cases of primary Sj\u00f6gren\u2019s syndrome. Chin Med J 123(22):3252\u20133257","journal-title":"Chin Med J"},{"issue":"5","key":"5397_CR27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53(5):1107\u20131114","journal-title":"Neurology"},{"issue":"2","key":"5397_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.24554","volume":"79","author":"I Kleiter","year":"2016","unstructured":"Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M, K\u00fcmpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Neuromyelitis Optica Study Group (2016) Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses. Ann neurol 79(2):206\u2013216","journal-title":"Ann neurol"},{"issue":"4","key":"5397_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S1474-4422(20)30066-1","volume":"19","author":"M Tahara","year":"2020","unstructured":"Tahara M, Oeda T, Okada K, Kiriyama T, Ochi K, Maruyama H, Fukaura H, Nomura K, Shimizu Y, Mori M, Nakashima I, Misu T, Umemura A, Yamamoto K, Sawada H (2020) Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 19(4):298\u2013306","journal-title":"Lancet Neurol"},{"key":"5397_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jns.2017.12.034","volume":"385","author":"Y Yang","year":"2018","unstructured":"Yang Y, Wang CJ, Wang BJ, Zeng ZL, Guo SG (2018) Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and lower dosages of rituximab among patients with neuromyelitis optica spectrum disorder. J Neurol Sci 385:192\u2013197","journal-title":"J Neurol Sci"},{"key":"5397_CR31","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.3389\/fimmu.2018.02066","volume":"9","author":"Q Huang","year":"2018","unstructured":"Huang Q, Wang J, Zhou Y, Yang H, Wang Z, Yan Z, Long Y, Yin J, Feng H, Li C, Lu Z, Hu X, Qiu W (2018) Low-dose mycophenolate mofetil for treatment of neuromyelitis optica spectrum disorders: a prospective multicenter study in south China. Front Immunol 9:2066","journal-title":"Front Immunol"},{"key":"5397_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jns.2016.09.035","volume":"370","author":"Y Xu","year":"2016","unstructured":"Xu Y, Wang Q, Ren HT, Qiao L, Zhang Y, Fei YY, Zhao Y, Cui LY (2016) Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: a prospective cohort study. J Neurol Sci 370:224\u2013228","journal-title":"J Neurol Sci"},{"issue":"39","key":"5397_CR33","first-page":"3056","volume":"94","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Fei Y, Niu J, Ren H, Zhao J, Wang Q, Xu Y (2014) Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease. Zhonghua\u00a0yi\u00a0xue\u00a0za\u00a0zhi 94(39):3056\u20133061","journal-title":"Zhonghua\u00a0yi\u00a0xue\u00a0za\u00a0zhi"},{"key":"5397_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.msard.2019.08.009","volume":"35","author":"W Huang","year":"2019","unstructured":"Huang W, Wang L, Zhang B, Zhou L, Zhang T, Quan C (2019) Effectiveness and tolerability of immunosuppressants and monoclonal antibodies in preventive treatment of neuromyelitis optica spectrum disorders: a systematic review and network meta-analysis. Mult Scler Relat Dis 35:246\u2013252","journal-title":"Mult Scler Relat Dis"},{"issue":"1","key":"5397_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Bombardieri S, Bootsma H, De Vita S, D\u00f6rner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Sis\u00f3-Almirall A, Tzioufas AG, Vitali C, EULAR-Sj\u00f6gren Syndrome Task Force Group (2020) EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis 79(1):3\u201318","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"5397_CR36","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurolo 6(9):805\u2013815","journal-title":"Lancet Neurolo"},{"issue":"4","key":"5397_CR37","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00415-019-09685-3","volume":"267","author":"W Zhang","year":"2020","unstructured":"Zhang W, Cui L, Zhang Y, Wang W, Wang R, Liu Z, Peng D, Jiao Y, Jiao J (2020) Questioning the existence of monophasic neuromyelitis optica spectrum disorder by defining a novel long-term relapse-free form from a large Chinese population. J Neurol 267(4):1197\u20131205","journal-title":"J Neurol"},{"key":"5397_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fneur.2020.00537","volume":"11","author":"E Khalilidehkordi","year":"2020","unstructured":"Khalilidehkordi E, Clarke L, Arnett S, Bukhari W, Jimenez Sanchez S, O\u2019Gorman C, Sun J, Prain KM, Woodhall M, Silvestrini R, Bundell CS, Abernethy D, Bhuta S, Blum S, Boggild M, Boundy K, Brew BJ, Brown M, Brownlee W, Butzkueven H, Broadley SA (2020) Relapse patterns in NMOSD: evidence for earlier occurrence of optic neuritis and possible seasonal variation. Front Neurol 11:537","journal-title":"Front Neurol"},{"issue":"2","key":"5397_CR39","doi-asserted-by":"publisher","first-page":"e947","DOI":"10.1212\/NXI.0000000000000947","volume":"8","author":"SH Kim","year":"2021","unstructured":"Kim SH, Jang H, Park NY, Kim Y, Kim SY, Lee MY, Hyun JW, Kim HJ (2021) Discontinuation of immunosuppressive therapy in patients with neuromyelitis optica spectrum disorder with aquaporin-4 antibodies. Neurol(R) Neuroimmunol Neuroinflamm 8(2):e947","journal-title":"Neurol(R) Neuroimmunol Neuroinflamm"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05397-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05397-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05397-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T11:04:17Z","timestamp":1733310257000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05397-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5397"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05397-0","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"19 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}